Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,450.00

Mettler-Toledo International (NYSE:MTD) had its price target hoisted by Morgan Stanley from $1,275.00 to $1,450.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an equal weight rating on the medical instruments supplier’s stock.

Other analysts also recently issued research reports about the stock. Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Stifel Nicolaus lifted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Monday. Weiss Ratings downgraded shares of Mettler-Toledo International from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, July 21st. Barclays upped their target price on Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the stock an “overweight” rating in a research note on Monday. Finally, Citigroup decreased their price target on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus target price of $1,461.27.

Mettler-Toledo International Stock Down 0.1%

Shares of NYSE MTD opened at $1,420.04 on Tuesday. The stock has a market capitalization of $28.46 billion, a P/E ratio of 31.96, a PEG ratio of 2.92 and a beta of 1.23. The stock’s fifty day moving average is $1,262.44 and its 200 day moving average is $1,273.12. Mettler-Toledo International has a 52 week low of $1,023.05 and a 52 week high of $1,525.17. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, topping the consensus estimate of $10.78 by $0.68. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter in the prior year, the business posted $10.09 earnings per share. Mettler-Toledo International’s revenue was up 4.5% compared to the same quarter last year. Sell-side analysts forecast that Mettler-Toledo International will post 47.35 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Gerry Keller sold 240 shares of the company’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $1,427.14, for a total transaction of $342,513.60. Following the completion of the transaction, the insider directly owned 259 shares in the company, valued at $369,629.26. This represents a 48.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Shawn Vadala sold 2,240 shares of the firm’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $1,432.00, for a total transaction of $3,207,680.00. Following the completion of the sale, the chief financial officer owned 5,579 shares in the company, valued at $7,989,128. This represents a 28.65% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 2,895 shares of company stock worth $4,149,711 in the last three months. 0.71% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Hedge funds and other institutional investors have recently bought and sold shares of the company. Evergreen Capital Management LLC boosted its position in shares of Mettler-Toledo International by 4.5% during the 4th quarter. Evergreen Capital Management LLC now owns 184 shares of the medical instruments supplier’s stock worth $257,000 after acquiring an additional 8 shares in the last quarter. Meridian Wealth Management LLC raised its position in shares of Mettler-Toledo International by 1.7% during the 4th quarter. Meridian Wealth Management LLC now owns 488 shares of the medical instruments supplier’s stock worth $680,000 after acquiring an additional 8 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Mettler-Toledo International by 2.7% during the 4th quarter. EverSource Wealth Advisors LLC now owns 302 shares of the medical instruments supplier’s stock worth $421,000 after acquiring an additional 8 shares in the last quarter. Values First Advisors Inc. boosted its holdings in Mettler-Toledo International by 1.3% in the first quarter. Values First Advisors Inc. now owns 625 shares of the medical instruments supplier’s stock valued at $789,000 after purchasing an additional 8 shares in the last quarter. Finally, Torray Investment Partners LLC increased its stake in Mettler-Toledo International by 0.5% in the first quarter. Torray Investment Partners LLC now owns 1,677 shares of the medical instruments supplier’s stock valued at $2,115,000 after purchasing an additional 8 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Trending Headlines about Mettler-Toledo International

Here are the key news stories impacting Mettler-Toledo International this week:

• Positive Sentiment: Analysts raised price targets: Stifel Nicolaus increased its target to $1,600, Wells Fargo lifted its target to $1,450, and Morgan Stanley raised its target from $1,275 to $1,450. Barclays also expects the shares to rise. These revisions support the potential for additional upside, although Morgan Stanley maintained an “equal weight” rating. Stifel Nicolaus price-target article Wells Fargo price-target article Morgan Stanley price-target article Barclays analyst article
• Positive Sentiment: Strong recent earnings performance: Mettler-Toledo reported quarterly EPS of $11.46, beating consensus by $0.68, while revenue reached approximately $1.03 billion and increased 4.5% year over year. The results provide fundamental support for the bullish analyst revisions.
• Neutral Sentiment: Analyst sentiment remains mixed: The consensus rating is “Hold,” with six Buy ratings and seven Hold ratings. The average price target is approximately $1,461, indicating limited-to-moderate upside from levels near $1,420.
• Negative Sentiment: Several insiders sold shares: CFO Shawn Vadala sold 2,240 shares worth about $3.21 million, reducing his position by 28.65%. Director Thomas P. Salice sold 415 shares for roughly $599,500, and Gerry Keller sold 240 shares worth approximately $342,500, cutting his holdings by 48.1%. The transactions may pressure investor sentiment, although the filings do not explain the reasons for the sales. Mettler-Toledo insider sales article

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.